Virus News and Research

Latest Virus News and Research

Abnormalities of blood vessels in the brain may play major role in development of schizophrenia

Scientists from Trinity College Dublin and the Royal College of Surgeons in Ireland have discovered that abnormalities of blood vessels in the brain may play a major role in the development of schizophrenia, a debilitating condition that affects around 1% of people in Ireland.

10 Oct 2017

TTUHSC El Paso researcher receives $420,000 grant to study mosquito-borne Zika virus

Haoquan Wu, Ph.D., associate professor in the Paul L. Foster School of Medicine, has received a two-year, $420,000 grant from the National Institute of Allergy and Infectious Disease to study the mosquito-borne virus Zika.

10 Oct 2017

High fat diet linked to increased risk of relapse in kids with MS

On the other hand, high vegetable intake may halve the risk of relapse, the findings indicate. Several genetic and environmental factors, including previous infection with Epstein Barr virus, exposure to cigarette smoke, and low vitamin D levels have all been associated with a heightened risk of MS.

9 Oct 2017

GW researchers receive NIH award to bring Zika vaccine trial to Brazil

The National Institute of Allergy and Infectious Disease of the National Institutes of Health awarded more than $2 million to a research team at the George Washington University School of Medicine and Health Sciences to facilitate a Zika vaccine trial in Brazil.

9 Oct 2017

Study finds abundant disease-transmitting mosquito species in deforested areas

Most disease-transmitting mosquito species live in deforested areas, a finding that may influence decisions on where and when to cut down trees, a new University of Florida study shows.

9 Oct 2017

Penn study explains how acute viral infections can linger

Infections caused by viruses, such as respiratory syncytial virus, or RSV, measles, parainfluenza, and Ebola, are typically considered acute. These viruses cause disease quickly and live within a host for a limited time. But in some cases, the effects of the infection, and presence of the virus itself, can persist.

6 Oct 2017

Ebola vaccine found to be safe and effective for adults and children in Africa

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

6 Oct 2017

FDA grants approval for new test to detect Zika virus in blood donations

The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors.

6 Oct 2017

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.

5 Oct 2017

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

A collaborative study conducted by the Miller School of Medicine, University of Miami has revealed that a monoclonal antibody “cocktail” inhibited zika virus (ZIKV) infection in primates.

5 Oct 2017

Scientists develop synthetic molecule effective at kicking and killing HIV

Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly reduce the chance of transmission from person to person.

5 Oct 2017

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc.

5 Oct 2017

Blood test for HPV could help identify cancer patients suitable for lower treatment doses

A blood test for the human papillomavirus, or HPV, may help researchers forecast whether patients with throat cancer linked to the sexually transmitted virus will respond to treatment, according to preliminary findings from the University of North Carolina Lineberger Comprehensive Cancer Center.

4 Oct 2017

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging (MRI) in addition to standard ultrasound (US) because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented during IDWeek 2017.

4 Oct 2017

Genital herpes was inherited from human ancestors

There are two main herpes simplex viruses that cause herpes in man – those that cause cold sores or HSV1 and those that cause genital herpes or HSV2. Humans and chimpanzees both were affected by HSV1 millions of years ago when their lineages split. HSV2 however did not leap on to humans until much later shows new research.

3 Oct 2017

Five important things everyone should know about cervical cancer

There are several types of gynecologic cancers that affect the female reproductive system, including endometrial, ovarian, cervical, vaginal and vulvar cancer.

3 Oct 2017

Hepatitis C drug’s lower cost paves way for Medicaid, prisons to expand treatment

Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn't qualify yet for the Medicaid program's criteria for treatment with a new class of highly effective but pricey drugs. The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.

3 Oct 2017

Virus News and Research

Latest Virus News and Research

Abnormalities of blood vessels in the brain may play major role in development of schizophrenia

TTUHSC El Paso researcher receives $420,000 grant to study mosquito-borne Zika virus

High fat diet linked to increased risk of relapse in kids with MS

GW researchers receive NIH award to bring Zika vaccine trial to Brazil

Study finds abundant disease-transmitting mosquito species in deforested areas

Penn study explains how acute viral infections can linger

Ebola vaccine found to be safe and effective for adults and children in Africa

FDA grants approval for new test to detect Zika virus in blood donations

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

Scientists develop synthetic molecule effective at kicking and killing HIV

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

Blood test for HPV could help identify cancer patients suitable for lower treatment doses

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Genital herpes was inherited from human ancestors

Five important things everyone should know about cervical cancer

Hepatitis C drug’s lower cost paves way for Medicaid, prisons to expand treatment

British technology offers ultimate surface protection against Aussie flu virus

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in